newsfilter
← Latest News
PR Newswire·

DURECT Corporation Reports Fourth Quarter and Full Year 2022 Financial Results and AHFIRM Trial Update

- Webcast of Earnings Call Today, March 7th at 4:30 p.m. ET - Topline data from AHFIRM trial expected in 2023 CUPERTINO, Calif., March 7, 2023 /PRNewswire / -- DURECT Corporation (NASDAQ:DRRX) today announced financial